ライフサイエンスコーパス: rheumatoid vasculitis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 101/*0401 may be of particular importance to rheumatoid vasculitis.

2 tion of SE presence, dose, and genotype with rheumatoid vasculitis.

3 evention, treatment or even as a trigger for rheumatoid vasculitis.

4 des for CD158j, is a genetic risk factor for rheumatoid vasculitis.

5 pact of biologic agents used to treat RA, on rheumatoid vasculitis.

6 ch as infliximab, have shown some benefit in rheumatoid vasculitis and Sjogren syndrome.

7 Rates of hospitalization for rheumatoid vasculitis and splenectomy in Felty's syndrom

8 Rates of hospitalization for rheumatoid vasculitis and splenectomy in Felty's syndrom

9 f cyclophosphamide in patients with systemic rheumatoid vasculitis, and methotrexate in the case of o

10 ere was a clear decline in the prevalence of rheumatoid vasculitis, and this decline remained evident

11 he genetic determinants that confer risk for rheumatoid vasculitis are not known, but patients with v

12 respectively, to determine the prevalence of rheumatoid vasculitis, as defined by the International C

13 itis nodosa, microscopic polyangiitis (MPA), rheumatoid vasculitis, Churg-Strauss syndrome (CSS), and

14 s significantly enriched among patients with rheumatoid vasculitis compared with normal individuals (

15 The incidence of rheumatoid vasculitis has declined significantly in the

16 was significantly different in patients with rheumatoid vasculitis in comparison with the control pop

17 Rheumatoid vasculitis is the most serious extra-articula

18 patients with RA who were hospitalized with rheumatoid vasculitis or to undergo splenectomy for Felt

19 relates, predictors, therapy and outcomes of rheumatoid vasculitis over the past decade.

20 results demonstrate a significant decline in rheumatoid vasculitis prevalence after 2000 in this nati

21 eakpoints representing a significant drop in rheumatoid vasculitis prevalence between the years 2000

22 To test for a decrease in rheumatoid vasculitis prevalence, breakpoint analysis wa

23 Rheumatoid vasculitis remains a rare yet challenging ext

24 (i.e., 1 or 2 alleles versus 0 alleles) and rheumatoid vasculitis (summary OR 1.4, 95% CI 0.7-2.7).

25 The risk of hospitalization for rheumatoid vasculitis was one-third lower in 1998-2001 t

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。